Just looking at the AF article: Something to keep in mind is Incyte has about 211 million OS while ONCS has far fewer, even after the latest warrants being exercised. If they have similar products, yet Incyte's product is worth about 11 billion, it makes you think ONCS could be bought out for well into the billions. Incyte is about $106 per share right now. If roughly half of their value is based on epacadostat, that would be roughly $50 per share of their value. I think this bodes well for ONCS.
Market Data 
Markets 
AI
